Figure 2. Lfng-eGFP-expressing cells are functional NSCs.
(A) Most Lfng-eGFP+ NSCs are quiescent. Bar graphs represent the total number of GFP+ cells (left panel), GFP+ NSCs (middle panel) and GFP+ ANPs (right panel) in 3 month-old Nestin-GFP and Lfng-eGFP mice (N = 4 per genotype) treated with temozolomide (TMZ). The difference between the two mouse models is most notable with respect to ANPs: while Nestin-GFP labels a large number of ANPs, Lfng-eGFP does not - it labels primarily quiescent cells. (B) Electroconvulsive shock (ECS) and physical exercise (PE) both activate Lfng-eGFP+ NSCs (N = 4 per group in ECS and N = 6 per group in PE). (C) Lfng-eGFP NSCs produce neuronal progeny. The relative number of newborn, BrdU+ progeny was quantified over a 30 day period (NSCs: Nestin-GFP+ or Lfng-eGFP+ cells with GFAP+ radial processes; ANPs: GFAP- Dcx- NeuN-; NBs: Dcx+ neuroblasts and immature neurons; GCs: NeuN+; Other: BrdU+ Dcx- NeuN- cells outside the SGZ; N = 4 per genotype per timepoint). Cumulative BrdU paradigm (four 150 mg/kg injections given 2 hr apart) was used to increase the yield of labeled newborn cells. N=Nestin-GFP mice, L=Lfng-eGFP mice. (D) The number of Lfng-eGFP+ NSCs declines over an 18 month period comparably to the number of Nestin-GFP+ NSCs (left panel; N = 4 per timepoint per genotype). However, the contribution of GFP+ cell types in the Nestin-GFP and Lfng-eGFP mice differs at different age (right panel). While Lfng-eGFP remains selective for NSCs during aging (p>0.15 for all timepoints, Tukey post-hoc test), Nestin-GFP labels significantly more non-neuroprogenitors in older mice (p<0.002; Tukey post-hoc test). Bars represent mean±SEM. NS=non-significant, *p<0.05, **p<0.001. See Figure 2—figure supplement 1 for further details.